iBio to present at plant-made pharmaceutical meeting in Brazil


iBio (NYSE AMERICAN:IBIO) is presenting at the Plant-Based Technology Trends Meeting in Meireles, Fortaleza, Brazil between December 2-to-4. The meeting is sponsored by Bio-Manguinhos/Fiocruz, a unit of the Brazilian Ministry of Health.

Sancha Salgueiro, a well-known business development executive focused on plant-made protein technologies and products, will be presenting, “Transient expression of therapeutic proteins in plants: a flexible platform for fast and affordable biologics manufacturing.”

iBio is a leader in developing plant-based biopharmaceuticals. It also provides a range of product and process development, analytical, and manufacturing services at its development and manufacturing subsidiary, iBio CDMO, in Bryan, Texas.

“We look forward to continuing our collaborative relationship with Bio-Manguinhos/Fiocruz as it implements its planned, important expansion of capabilities in the plant-based biopharmaceutical field,” Robert Kay, chairman and CEO of iBio, said in a statement.

Michelle Carr